#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13256	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2176	605.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1516	1516	C	766	C	726	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23708	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3441	686.0	0	.	n	.	0	A20C	SNP	20	20	A	196	196	C	455	C,A	435,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23708	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3441	686.0	0	.	n	.	0	T695C	SNP	695	695	T	871	871	C	761	C,T	707,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23708	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3441	686.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1814	1814	G	846	G	792	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23708	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3441	686.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2147	2147	C	806	C,T	750,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23708	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3441	686.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2221	2221	A	785	A	752	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23708	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3441	686.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2773	2773	C	753	C	711	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23708	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3441	686.0	0	HET	.	.	.	A412G,C	.	412	412	A	588	588	A	725	A,G,C	535,131,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1896	folP	855	855	100.0	folP.l15.c4.ctg.1	1633	115.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1100	1102	AGC	198;202;201	A;G;C	188;192;190	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4952	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3432	143.8	1	SNP	p	S91F	1	.	.	271	273	TTC	609	611	TTC	177;176;176	T;T;C	166;163;162	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4952	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3432	143.8	1	SNP	p	G95N	0	.	.	283	285	GGC	621	623	GGC	170;168;170	G;G;C	157;155;156	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4952	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3432	143.8	1	SNP	p	D95G	1	.	.	283	285	GGC	621	623	GGC	170;168;170	G;G;C	157;155;156	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1382	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1480	93.0	0	.	p	.	0	F184L	NONSYN	550	552	TTC	977	979	TTG	168;169;169	T;T;G	160;163;161	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1382	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1480	93.0	1	SNP	p	G45D	0	.	.	133	135	GGC	560	562	GGC	152;148;146	G;G,A;C	144;140,1;139	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	724	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	950	75.2	0	.	n	.	0	A197.	DEL	197	197	A	580	580	A	177	A	167	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4648	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2930	158.1	1	SNP	p	D86N	0	.	.	256	258	GAC	586	588	GAC	148;147;148	G;A;C	145;140;146	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4648	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2930	158.1	1	SNP	p	S87R	1	.	.	259	261	CGT	589	591	CGT	148;149;151	C;G;T	146;147;148	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4648	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2930	158.1	1	SNP	p	R87I	0	.	.	259	261	CGT	589	591	CGT	148;149;151	C;G;T	146;147;148	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4648	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2930	158.1	1	SNP	p	R87W	0	.	.	259	261	CGT	589	591	CGT	148;149;151	C;G;T	146;147;148	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4648	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2930	158.1	1	SNP	p	S88P	0	.	.	262	264	TCC	592	594	TCC	152;148;151	T;C;C	149;144;148	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3888	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2694	143.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1668	1670	GGC	191;191;188	G;G;C	177;179;176	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3566	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2540	139.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1352	1354	GCA	183;186;189	G;C;A	170;173;175	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3566	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2540	139.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1355	1357	ATC	192;191;195	A;T;C	178;177;180	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3566	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2540	139.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1367	1369	GTG	204;203;202	G;T;G	191;188;190	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3566	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2540	139.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1367	1369	GTG	204;203;202	G;T;G	191;188;190	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3566	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2540	139.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1871	1873	ACC	181;182;184	A;C;C	162;168;171	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3566	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2540	139.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1925	1927	GCG	166;162;162	G;C,G;G	148;134,1;143	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3566	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2540	139.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1925	1927	GCG	166;162;162	G;C,G;G	148;134,1;143	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3566	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2540	139.8	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2048	2050	AGC	155;154;158	A;G;C	146;145;146	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3566	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2540	139.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2057	2059	GGC	156;157;152	G;G;C	147;149;143	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3566	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2540	139.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2075	2077	CCG	127;128;129	C,G;C,G;G	92,5;93,1;100	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5154	ponA	2397	2397	99.92	ponA.l15.c4.ctg.1	3105	165.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1952	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1824	106.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	560	560	C	126	C,A	117,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2564	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1703	150.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	626	628	GAA	234;235;237	G;A;A	221;223;223	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2564	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1703	150.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1037	1039	TCA	207;209;207	T;C;A	196;199;198	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2564	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1703	150.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1166	1168	GTC	197;196;195	G;T;C	189;189;188	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2564	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1703	150.0	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1178	1180	TCT	195;198;200	T;C;T	192;194;196	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2564	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1703	150.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1496	1498	GCA	171;174;171	G;C;A	160;162;162	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2564	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1703	150.0	1	SNP	p	G120K	1	.	.	358	360	AAG	872	874	AAG	212;210;207	A;A,G;G	204;202,1;199	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2564	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1703	150.0	1	SNP	p	A121D	1	.	.	361	363	GAC	875	877	GAC	206;207;210	G;A;C	194;195;200	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2564	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1703	150.0	1	SNP	p	D121N	0	.	.	361	363	GAC	875	877	GAC	206;207;210	G;A;C	194;195;200	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9156	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4964	184.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1012	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1107	91.0	1	SNP	p	V57M	1	.	.	169	171	ATG	523	525	ATG	214;215;211	A;T;G	201;200;198	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
